Connection

Mark Rubinstein to Immunogenicity, Vaccine

Back to Details
This is a "connection" page, showing publications Mark Rubinstein has written about Immunogenicity, Vaccine.
Mark Rubinstein
Connection Strength
0.051
Immunogenicity, Vaccine
  1. COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer. Cancer Cell. 2022 02 14; 40(2):117-119.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.